View Older Stories View More Recent Stories

Mar 22, 2021 04:00PM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020
Mar 22, 2021 06:01AM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 18, 2021 09:08PM Form 4 Oric Pharmaceuticals, For: Mar 16 Filed by: ORBIMED ADVISORS LLC
Mar 15, 2021 08:56PM Form 4 Oric Pharmaceuticals, For: Mar 11 Filed by: ORBIMED ADVISORS LLC
Mar 4, 2021 07:30AM Syros Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
Mar 4, 2021 06:02AM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Mar 3, 2021 06:55PM Form 4 SpringWorks Therapeutics For: Mar 01 Filed by: ORBIMED ADVISORS LLC
Mar 3, 2021 04:01PM BlossomHill Therapeutics Closes $71M Series A Financing
Mar 3, 2021 04:01PM BlossomHill Therapeutics Closes $71M Series A Financing
Mar 3, 2021 11:10AM Best Penny Stocks To Buy After A Pullback? 3 To Watch Right Now
Mar 2, 2021 06:02AM Form SC 13G/A Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 2, 2021 06:01AM Form SC 13D Decibel Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 26, 2021 06:06AM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Feb 25, 2021 04:05PM Natera Reports Fourth Quarter and Year 2020 Financial Results
Feb 23, 2021 06:02AM Form SC 13D Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 22, 2021 03:48PM Form SC 13D Gemini Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 19, 2021 06:03AM Form SC 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 18, 2021 09:39PM Form 4 Adicet Bio, Inc. For: Feb 12 Filed by: ORBIMED ADVISORS LLC
Feb 17, 2021 05:09PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 16, 2021 05:22PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 12, 2021 05:18PM Form SC 13G/A Xenon Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:12PM Form SC 13G VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:11PM Form SC 13G Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:09PM Form SC 13G Strongbridge Biopharma Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:08PM Form SC 13G/A PROTHENA CORP PUBLIC Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:07PM Form SC 13G OTONOMY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:05PM Form SC 13G/A ObsEva SA Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:02PM Form SC 13G Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 05:00PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:57PM Form SC 13G Larimar Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:56PM Form SC 13G/A Krystal Biotech, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:54PM Form SC 13G/A Kala Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:53PM Form SC 13G/A Inspire Medical Systems, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:50PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:48PM Form SC 13G Forte Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:46PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:45PM Form SC 13G/A Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:43PM Form SC 13G/A Applied Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:42PM Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 12, 2021 04:38PM Form SC 13G/A Adverum Biotechnologies, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2021 09:21PM Form 3 Decibel Therapeutics, For: Feb 11 Filed by: ORBIMED ADVISORS LLC
Feb 10, 2021 05:49PM Form 3 Gemini Therapeutics, For: Feb 05 Filed by: ORBIMED ADVISORS LLC
Feb 9, 2021 06:05AM Form SC 13D/A Arcutis Biotherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 5, 2021 08:30AM Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Jan 29, 2021 06:13AM Form SC 13D/A Prevail Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 28, 2021 01:48PM Form SC 13D/A Passage BIO, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 26, 2021 05:21PM Form 4 Prevail Therapeutics For: Jan 22 Filed by: ORBIMED ADVISORS LLC
Jan 25, 2021 07:00AM Umoja Biopharma Appoints Dr. Robert Glassman to its Board of Directors
Jan 21, 2021 04:47PM Form SC 13D Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Jan 19, 2021 07:00AM Terns Announces FDA Clearance of Investigational New Drug (IND) Application for First-in-Human Phase 1 Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH
View More Recent Stories View Older Stories